Cansino Biologics, Inc. Class ASSE: 688185

Announcement on Participating in the 2024 Semi-Annual Collective Performance Briefing for Pharmaceutical and Biological Products

· Issued by Cansino Biologics, Inc. Class A via Shanghai Stock Exchange
Announcement on Participating in the 2024 Semi-Annual Collective Performance Briefing for Pharmaceutical and Biological Products

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis